Universal Ibogaine Inc. (IBO.V)

CAD 0.02

(0.0%)

Revenue Summary of Universal Ibogaine Inc.

Universal Ibogaine Inc.'s latest annual revenue in 2022 was 1.07 Million CAD , down 0.0% from previous year.
Universal Ibogaine Inc.'s latest quarterly revenue in 2023 Q3 was 428.32 Thousand CAD , up 937.95% from previous quarter.
Universal Ibogaine Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
Universal Ibogaine Inc. reported a annual revenue of - CAD in annual revenue 2020, down 0.0% from previous year.
Universal Ibogaine Inc. reported a quarterly revenue of 41.26 Thousand CAD for 2023 Q2, down 0.0% from previous quarter.
Universal Ibogaine Inc. reported a quarterly revenue of - CAD for 2023 Q1, down -100.0% from previous quarter.

Annual Revenue Chart of Universal Ibogaine Inc. (2022 - 2018)

Historical Annual Revenue of Universal Ibogaine Inc. (2022 - 2018)

Year	Revenue	Revenue Growth
2022	1.07 Million CAD	0.0%
2021	- CAD	0.0%
2020	- CAD	0.0%
2019	- CAD	0.0%
2018	- CAD	0.0%

Year	Revenue	Revenue Growth
2023 Q3	428.32 Thousand CAD	937.95%
2023 Q2	41.26 Thousand CAD	0.0%
2023 Q1	- CAD	-100.0%
2022 Q1	137.32 Thousand CAD	0.0%
2022 FY	1.07 Million CAD	0.0%
2022 Q4	131.2 Thousand CAD	-64.46%
2022 Q3	369.12 Thousand CAD	-14.78%
2022 Q2	433.15 Thousand CAD	215.43%
2021 Q4	- CAD	0.0%
2021 Q2	- CAD	0.0%
2021 Q3	- CAD	0.0%
2021 FY	- CAD	0.0%
2021 Q1	- CAD	0.0%
2020 FY	- CAD	0.0%
2020 Q4	- CAD	0.0%
2020 Q3	- CAD	0.0%
2020 Q2	- CAD	0.0%
2020 Q1	- CAD	0.0%
2019 Q1	- CAD	0.0%
2019 FY	- CAD	0.0%
2019 Q4	- CAD	0.0%
2019 Q3	- CAD	0.0%
2019 Q2	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q4	- CAD	0.0%
2018 Q3	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 Q2	- CAD	0.0%
2017 Q4	- CAD	0.0%

Peer Revenue Comparison of Universal Ibogaine Inc.

Name	Revenue	Revenue Difference
Arch Biopartners Inc.	1.98 Million CAD	46.018%
Covalon Technologies Ltd.	26.59 Million CAD	95.974%
Hemostemix Inc.	- CAD	-Infinity%
Kane Biotech Inc.	148.98 Thousand CAD	-618.757%
MedMira Inc.	432.52 Thousand CAD	-147.568%
Marvel Biosciences Corp.	- CAD	-Infinity%
NervGen Pharma Corp.	- CAD	-Infinity%
XORTX Therapeutics Inc.	- CAD	-Infinity%